Skip to main content
AAN.com
Articles
October 7, 2015
Open AccessLetter to the Editor

Does intraoperative neurophysiologic monitoring matter in noncomplex spine surgeries?

December 15, 2015 issue
85 (24) 2151-2158

Abstract

Objectives:

To determine associations between intraoperative neurophysiologic monitoring (IOM) for spinal decompressions and simple fusions with neurologic complications, length of stay, and hospitalization charges.

Methods:

Adult discharges in the Nationwide/National Inpatient Sample (NIS) (2007–2012) with spinal decompressions and simple spinal fusions were included. Revision surgeries, instrumentations, complicated approaches, and tumor- and trauma-related surgeries were excluded. Extracted data included patient demographics, medical comorbidities, primary spinal surgery type, and hospital characteristics. Bivariate and multiple regression analyses using NIS survey design variables correlated IOM use with neurologic complications, hospital charges, and length of stay.

Results:

IOM was reported in 4.9% of an estimated 1.1 million discharges in the weighted sample. Discharges reporting IOM were more often privately insured (61% vs 57%, p < 0.001) and had slightly more comorbidities (25% vs 24% with 3+ comorbidities, p = 0.01). Spinal fusions more often reported IOM than decompressions. The IOM group had fewer neurologic complications (0.8% vs 1.4% of controls) with no difference in length of stay (3.0 days for each group), but increased hospital charges (39% greater). Multiple regression adjustment showed significant associations of IOM with fewer neurologic complications (odds ratio 0.60, 95% confidence interval [CI] 0.47, 0.76, p < 0.001), while the estimated percentage of hospital charges was sizably diminished from the unadjusted analysis (IOM effect +9%, 95% CI +4%, +13%, p < 0.001), and length of stay was reduced (IOM effect −0.26 days, 95% CI −0.42, −0.11, p < 0.001).

Conclusions:

IOM was associated with better clinical outcomes and some increased hospital charges among discharges of simple spinal fusions and laminectomies in a large, multiyear, nationally representative dataset.
Spinal decompressions and fusions are among the most widely performed and costly surgeries in the United States,1 carrying a small but real chance of neural injury,25 with profound consequences for patient quality of life and health care costs.6 Intraoperative neurophysiologic monitoring (IOM) can detect impending neurologic compromise, alerting the operating team to take action to avoid injury. The availability of IOM in the United States is reported to be high,7 but the actual rate of IOM usage in spinal surgeries is largely unknown, and the decision to use IOM generally rests with the surgeon.8
The effectiveness of IOM has recently been challenged by empirical evaluations using retrospective case series and observational studies.912 Several of these focus on surgeries where the perceived risk of postoperative deficits is small, concluding that IOM adds cost with no difference in clinical outcomes. These reports amplify the uncertainty of IOM effectiveness for spinal surgeries.
In this analysis, we assess the utilization of IOM in spinal decompressions and simple fusions in a large nationally representative dataset and test the hypothesis that these surgeries have better outcomes when performed with IOM.

METHODS

Data source.

We examined cross-sectional inpatient discharge data from the Nationwide Inpatient Sample (2007–2011),13 redesigned as the National Inpatient Sample for 201214 (NIS), the largest all-payer dataset of inpatient hospitalizations in the United States, comprising a 20% stratified sample of nonfederal community hospitals, with over 8 million discharges from over 1,000 hospitals in 46 states for 2012. Pooling of data over multiple years for analysis of trend has been provided through data design variables and instruction by the Healthcare Utilization Project of the Agency for Healthcare Research and Quality.15,16 The sample period started with introduction of ICD-9-CM code for IOM on October 1, 2007,17 ending December 31, 2012.

Standard protocol approvals, registrations, and patient consents.

The University of Washington Institutional Review Board designated the NIS as a de-identified publicly available dataset and associated research projects do not require ethics approval or review. The study was carried out in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)18 guidelines for observational studies.

Search algorithm and inclusion/exclusion criteria.

We searched the NIS 2007–2012 datasets for adult inpatient discharges containing single-level Clinical Classification Software (CCS)19 grouper procedure coding spinal decompressions (CCS = 3) and spinal fusions (CCS = 158). We searched for IOM (ICD-9-CM 00.94) among ICD-9 coded procedures. We excluded revisions, surgeries with instrumentation and prosthetic discs, anterior and dorsolateral approach lumbar fusions, atlanto-axial fusions, posterior cervical fusions, fusions involving more than 3 vertebrae, and fusions involving combined anterior and posterior approaches. We also excluded discharges involving trauma or neoplasms. The selection process is detailed in figure e-1 on the Neurology® Web site at Neurology.org.

Data extraction, outcomes of interest, and model specification.

Variables were determined by Andersen and Newman20 criteria of enabling, predisposing, and need factors of health care utilization. Age, sex, race, 3rd-party payer status, zip code–related income, comorbidities, year and quarter of discharge, primary surgery subtype (discectomy, laminectomy, anterior cervical fusion, or thoracolumbar fusion), number of coded spinal surgical procedures, number of nonsurgical procedures (excluding IOM), total hospital charges, hospital annual discharge volume, hospital teaching status, hospital geographic region, and urban vs rural hospital status were abstracted as independent variables. Comorbidity scoring was calculated using the Elixhauser et al.21 method, parsed into 4 dummy categories (0, 1, 2, 3, or more).22 Discharge years were treated as categorical variables. Hospital discharge volume was a continuous measure, while other hospital-specific variables were categorical terms.
We were interested in 1 clinical and 2 nonclinical outcomes. The clinical outcome was the presence of ICD-9 diagnostic coding for neurologic complications resulting from any services or procedures (ICD-9 997.0, 997.00, 997.01, 997.02, 997.09) in the reported discharge diagnoses. Nonclinical outcomes were the duration and the total charges of hospitalization.

Statistical analysis.

Analyses utilized the NIS complex sample design (probability weights, stratification, and clustering) for accurate national-level estimates. Differences in totals, proportions, or means of reported variables among the exposure groups were evaluated through 2-sample t test and Pearson χ2.23 IOM and relevant spine surgeries were assessed for annual change in the sample and at the hospital level. Bivariate (dependent and treatment variable only) and multiple regression analyses were performed for association of IOM with the clinical and nonclinical outcomes. Multiple regressions included patient demographics, primary surgery subtype, comorbidities, and hospital variables. Logistic regression modeled IOM and neurologic complications, reporting odds ratios (ORs) and 95% confidence intervals (CIs). Hospital charges were inflated to 2012 dollars using the Consumer Price Index for medical expenditures,24 then evaluated using a generalized linear model (gamma family) with log link for best fit. Attributable charges were reported as percentage of overall charges. Length of stay was evaluated with Poisson regression, reporting marginal effects in days. Observations with missing data were analyzed for bias and excluded if randomly distributed between treatment groups or outcomes. Significance was set at p ≤ 0.05. All statistical testing was performed using STATA 12.1 (StataCorp, College Park, TX).

Subgroup analysis: Primary spine surgery subtypes.

Descriptive statistics regarding rates of IOM use and neurologic complications, hospital charges, and length of stay were performed for association of the primary surgery subtypes of discectomy, laminectomy, cervical fusion, or thoracolumbar fusion. Inferential analyses were not performed by subgroup, owing to the anticipated reduction in sample size from the main analysis.

Sensitivity analyses.

To address the availability of IOM, we limited the sample to discharges from hospitals reporting at least one IOM procedure in the same calendar year. We repeated the bivariate and multiple regression analyses for the clinical and nonclinical outcomes.

RESULTS

Study sample.

An estimated 1.1 million discharges (234,067 unweighted observations) met inclusion criteria for the study period with 4.9% reported usage of IOM. Missing data accounted for <2% of observations for all covariates except race, where 12% of data in the original sample were missing. There were no missing data on primary surgery or clinical comorbidities. Between IOM and non-IOM surgeries, there was no difference in subject age or sex. IOM recipients were slightly more likely to be nonwhite, have private insurance, and come from the highest income quartile. Simple fusions were more common in monitored than unmonitored surgeries. Regional variation in IOM reporting was reflected in higher IOM prevalence in the Western geographic region (38% of total). IOM was not more likely to be performed at teaching hospitals. See table 1 for details.
Table 1 Sample characteristics by IOM status

Yearly IOM reporting.

IOM reporting grew at an annual rate of 50.8% for the full years of 2008–2012, while annual discharge estimates reporting simple fusions and laminectomies grew only 6.9% per year. Hospitals reporting IOM use in simple fusions and laminectomies increased from 292 in 2008 to 622 in 2012, an increase of 23% per year. The rate of IOM reporting in simple fusions and laminectomies in these hospitals was nearly twice the total yearly average (14.1% vs 7.1%) (table 2).
Table 2 Estimated annual totals and reported rates of IOM and decompressions and simple fusions

Outcomes.

Neurologic complications were reported in 1.4% of unmonitored surgeries and 0.8% of monitored surgeries. Following multiple logistic regression, the adjusted OR for neurologic complications was 0.60 (95% CI 0.46, 0.76, p < 0.001). Estimated hospitalization charges were 39% greater with IOM ($62,999 vs $45,266), falling to a 9% increase (95% CI 4%, 13%, p < 0.001) after multiple regression adjustment. Length of stay was no different in the 2 groups (3.0 days for both), but a small marginal decrease (0.26 days, 95% CI 0.11, 0.42, p < 0.001) attributable to IOM was observed after multiple regression (tables 3 and 4).
Table 3 Sample-weighted clinical and nonclinical outcomes by IOM status
Table 4 Bivariate and multiple regression–adjusted sample-weighted associations of IOM with neurologic complications, percentage of total hospital charges, and length of stay (marginal effect, in days)

Subgroup analysis.

Descriptive analyses of the outcomes of 4 subgroups by primary surgery subtype were generally consistent with the main analysis. Laminectomies had the highest neurologic complication rate, with the largest reduction in complications for IOM usage (2.7% vs 1.7%), while anterior cervical fusions had the smallest complication rate (0.2% vs 0.15% for IOM and no IOM groups, respectively). Length of stay was largely unchanged by IOM status and sample-weighted unadjusted costs were greater for IOM in all groups (table 5).
Table 5 Subgroup analysis: Estimated treatment group sample sizes, clinical and nonclinical outcomes by primary surgery subtype

Sensitivity analysis.

When limiting the sample to discharges in hospitals reporting any IOM for simple fusions and laminectomies in the same calendar year, the number of discharges in the non-IOM group was reduced by 38% from the main analysis. Inferential analyses from this sample were consistent with the main analysis, showing significant reduction in neurologic complications, increased total charges, and reduced length of stay in the IOM group, which were robust to multiple regression (table e-1).

DISCUSSION

In a large, nationally representative and publicly available dataset, IOM usage was associated with significantly fewer neurologic complications in spinal laminectomies and fusions, results that were robust to multiple regression adjustment. Total hospital charges for monitored patients were greater, albeit the magnitude of difference in charges was substantially reduced following multiple regression adjustment. The adjusted marginal effect of IOM on length of stay was a reduction in stay. The sensitivity analysis, limiting the sample only to hospitals that perform IOM, did not substantially alter the associations between IOM and neurologic complications, hospital charges, and length of stay from the main analysis.
This analysis provides a counterpoint to a recent study of the Truven Marketscan database10 (hereafter referred to as “the Marketscan study”), which looked at single-level surgeries, excluding surgeries with greater risks. We also excluded more complex surgeries and surgeries that carried larger presumptive risks, leaving decompressions and simple fusions. Our article differs from the Marketscan study in the dataset used, which is episodic and not longitudinal, therefore the unit of analysis is discharges, not patients followed over time. The NIS reports procedures using ICD-9-CM procedure codes instead of Current Procedure Terminology (CPT) coding, so identification of the sample population is somewhat different in our analysis as well. Further distinctions from the Marketscan study are detailed below.
Our first major finding is that reporting of IOM occurs in a minority of laminectomies and simple spinal fusions. In our sample, fewer than 5% of surgeries reported IOM use. Monitored surgeries were more often privately insured, had 3 or more comorbidities, were fusion surgeries, and occurred on the West coast than unmonitored surgeries. IOM reporting increased annually by over 50% per year, suggesting that this may have been related to the relative newness of the code for IOM (introduced FY 2008) and some IOM services may have gone unreported. The number of monitored surgeries did not increase markedly in 2012, although this may be related to changes in sampling techniques in the NIS relative to previous years.15 The rate of reported IOM increased to nearly 10% in the sensitivity analysis, which limited the sample to only surgeries at hospitals reporting IOM. This latter figure is closer to the 12% IOM usage in the Marketscan study, although far below the 65% rate in the Scoliosis Research Society (SRS) data,9 and contrasts with a 2007 survey of US spinal surgeons,7 where 95% of respondents reported access to electrophysiologic monitoring in the operating room.
Our second major finding is that IOM is associated with better clinical outcomes. The NIS does not indicate whether diagnoses existed prior to admission. We did not include poorly reported ICD-9 codes for nerve root or spinal cord injury (occurring 20 and 229 times, respectively, in a published analysis of over 440,000 spine cases in the NIS from 2007 to 201125) as these could not definitively be determined to have occurred during the admission. Therefore, we focused on ICD-9 coding for neurologic complications, reported in prior large administrative claims studies of iatrogenesis from spinal surgeries. The extent and severity of neurologic complications cannot be ascertained from the data. The rate of neurologic complications seen here is consistent with previous reports,4,26 including the SRS study, which found the incidence of new neurologic deficits at 1.1%,9 albeit higher than described in the Marketscan study, which focused on perceived low-risk surgeries where neurologic complication rates were less than 1%. In our sample, neurologic complications were reported nearly twice as often (1.4% vs 0.8%) in the unmonitored group than in those with IOM, an effect that retained significance after adjustment. In subgroup analysis, the rate of neurologic complications was greater in the unmonitored group for all primary surgery subtypes save anterior cervical fusions, which reported a very low rate (<0.2%), compounding uncertainty for this subgroup. Laminectomies had the highest rate and the widest discrepancy between IOM and non-IOM neurologic complications (2.7% vs 1.7%), suggesting that monitoring may have the largest benefit for these procedures.
Compared to prior analyses, we show lower neurologic complications for monitored surgeries. The SRS analysis of a registry requiring surgeons to submit cases to gain society membership may have suffered from selection and recall biases and also was a different population (scoliosis corrections). The Marketscan study, having a similar population of surgeries, elected to use a different analytic method, propensity score matching, to achieve pseudorandomization of the treatment27 (IOM). This methodology elected to evaluate the latent tendency to select IOM by factors such as associated bone morphogenic protein use, ignoring year of surgery (2006–2010) and prior IOM usage. While we pooled our results adjusted from primary surgery subtype to obtain an overall estimate of IOM efficacy, the Marketscan study restricted inferential analysis within subgroups, parsing sample sizes and increasing uncertainty, which was further compounded by excluding the majority of untreated subjects through matching. Like our analysis, among the Marketscan study's subgroups, IOM benefit was greatest in laminectomies (0 neurologic complications for monitored surgeries compared to 1.18% in unmonitored surgeries), and the lowest neurologic complications were seen in anterior cervical fusions (<0.2%).
Our third major finding is that while total hospital charges are greater with IOM use, length of stay may be improved. We posit that the increased usage of IOM in more costly fusion surgeries may account for the greater unadjusted charges and mask reductions in unadjusted length of stay. In this study, adjusting for primary surgical procedure, demographics, comorbidities, and hospital factors reduced the mean percentage of charges attributable to IOM from 39% to 9% of total charges, which remained significant. These do not appear to be a function of length of stay, which was significantly reduced in the monitored groups after adjustment (0.3 days). An approximately 10% reduction in length of stay is desirable for both surgeons, for whom longer stays are associated with greater iatrogenic complications,28 and for cost-conscious 3rd-party payers. Our findings on hospital charges are in line with the result of differences in allowed payments reported in the Marketscan study, which range from 6% to 24% greater in the IOM group after matching. We differ in indexing fiscal outcomes on a particular year (2012), and including calendar year in outcome adjustment models. Moreover, differences in total hospital charges and allowed payments do not account for complexities in fixed and variable labor and equipment costs and may reflect a host of other services not captured in multivariable adjustment. Postmatching length of stay was also less in the monitoring group in the Marketscan study for 3 of 4 surgery types (anterior cervical fusion, lumbar fusion, and lumbar discectomy).
Although we focused on comparatively low-risk surgeries, the clinical impact of IOM suggested by our analysis is substantial. Here, the main clinical outcome of IOM use, a reduction in neurologic complications by nearly half, is important even when the risk is less than 2%. In a cost-consequences simulation model,29 the likelihood of preventing a neurologic complication was calculated as the baseline risk of neurologic complication for the surgery × diagnostic sensitivity of IOM × probability of prevention of neurologic complication given an IOM alert. Our results are consistent with that model's outcome of a 49% reduction in relative risk with IOM. Given an absolute risk reduction of 1.4%–0.8% = 0.6%, 167 cases would need to be monitored to spare one neurologic complication. Although hospital charges appear to be greater in monitored surgeries, the actual cost of IOM should be set against a lifetime of lost wages and health care costs from neurologic complications (including spinal cord injury) of upwards of a million or more dollars.6 In a separate published cost-benefit analysis,6 IOM was cost-neutral even when the baseline risk is as low as 0.3%, far lower than the overall risk of surgeries in this sample. When disability and postoperative quality of life are factored into the equation, IOM may be invaluable. This effect is magnified when one realizes the hundreds of thousands of surgical cases performed annually and the tiny minority that are currently monitored.
There are a number of limitations to this analysis. Sample sizes are enormous, and can overemphasize minor differences in the data.30 We rely on accurate coding of spinal surgeries, IOM procedures, and clinical conditions. Surgical complications in administrative claims may be inaccurately reported, leading both to underreporting and overreporting compared to prospectively collected registry data.31 The NIS does not use CPT coding, which could also delineate modalities (evoked potentials and EMG) used during IOM. We cannot ascertain the level of expertise of the monitoring professional, which could range from a surgeon using an automated EMG device32 to a board-certified, fellowship-trained neurologist, nor whether the monitoring physician was in the operating room or stationed off-site.33 The relatively low rate of IOM reporting in the main analysis is also potentially problematic. However, as the act of reporting the ICD-9-CM IOM code is probably not related to the clinical or nonclinical outcomes of interest, the assumption of the authors is that IOM reported here represents a random sampling of discharges with IOM, where some unreported IOM is present in the unmonitored group. The code would be unlikely to be reported erroneously, where nonreporting is much more likely. This would have the effect of biasing the results toward the null, so the true effect of IOM may be greater in magnitude than that depicted here. Moreover, the sensitivity analysis shows that the main effects of IOM hold true even when removing surgical cases from hospitals that never report IOM. Finally, the associations seen here cannot be interpreted to be causal in this retrospective analysis of cross-sectional data.
In spite of these limitations, our study demonstrates that IOM is associated with improved outcomes for spinal surgeries in a large, nationally representative dataset. Certainly, more research is needed to confirm these findings. Still, the sample size needed for a traditional randomized clinical trial may be cost-prohibitive,34 and ethical issues have been raised regarding randomized controlled trials in IOM.35,36 We suggest that the next important step would be the identification of longitudinal changes to neurologic status and differential effects of baseline IOM modalities with on-site oversight by neurophysiologists, with remote oversight, and surgeon-directed automated EMG in a large, granular dataset. Ultimately, a prospective collection of longitudinal data in a registry format would help overcome reporting biases for both identification of monitored patients and accurate determination of outcomes. The results would be helpful in decisions to encourage or discourage the use of IOM through coverage and reimbursement decisions from public and private payers.

GLOSSARY

CCS
Clinical Classification Software
CI
confidence interval
CPT
Current Procedure Terminology
ICD-9-CM
International Classification of Diseases–9–clinical modification
IOM
intraoperative neurophysiologic monitoring
NIS
Nationwide Inpatient Sample or National Inpatient Sample
OR
odds ratio
SRS
Scoliosis Research Society

Data Supplement

One figure and one table; one PDF file.
Neurology® data supplements are not copyedited before publication. Published editorials and translations have been copyedited. © 2015 American Academy of Neurology. Files in this Data Supplement:

Supplementary Material

File (12.15.15_does_intraoperative_neurophysiologic.pdf)
File (figure_e-1-table_e-1.pdf)

REFERENCES

1.
Elixhauser A, Andrews RM. Profile of inpatient operating room procedures in US hospitals in 2007. Arch Surg 2010;145:1201–1208.
2.
Cramer DE, Maher PC, Pettigrew DB, Kuntz CT. Major neurologic deficit immediately after adult spinal surgery: incidence and etiology over 10 years at a single training institution. J Spinal Disord Tech 2009;22:565–570.
3.
Yadla S, Malone J, Campbell PG, et al. Early complications in spine surgery and relation to preoperative diagnosis: a single-center prospective study. J Neurosurg Spine 2010;13:360–366.
4.
Nasser R, Yadla S, Maltenfort MG, et al. Complications in spine surgery. J Neurosurg Spine 2010;13:144–157.
5.
Campbell PG, Yadla S, Malone J, et al. Complications related to instrumentation in spine surgery: a prospective analysis. Neurosurg Focus 2011;31:E10.
6.
Ney JP, van der Goes DN, Watanabe JH. Cost-benefit analysis: intraoperative neurophysiological monitoring in spinal surgeries. J Clin Neurophysiol 2013;30:280–286.
7.
Magit DP, Hilibrand AS, Kirk J, et al. Questionnaire study of neuromonitoring availability and usage for spine surgery. J Spinal Disord Tech 2007;20:282–289.
8.
Fehlings MG, Brodke DS, Norvell DC, Dettori JR. The evidence for intraoperative neurophysiological monitoring in spine surgery: does it make a difference? Spine 2010;35:S37–S46.
9.
Hamilton DK, Smith JS, Sansur CA, et al. Rates of new neurological deficit associated with spine surgery based on 108,419 procedures: a report of the scoliosis research society morbidity and mortality committee. Spine 2011;36:1218–1228.
10.
Cole T, Veeravagu A, Zhang M, Li A, Ratliff JK. Intraoperative neuromonitoring in single-level spinal procedures: a retrospective propensity score-matched analysis in a national longitudinal database. Spine 2014;39:1950–1959.
11.
Garces J, Berry JF, Valle-Giler EP, Sulaiman WA. Intraoperative neurophysiological monitoring for minimally invasive 1- and 2-level transforaminal lumbar interbody fusion: does it improve patient outcome? Ochsner J 2014;14:57–61.
12.
Traynelis VC, Abode-Iyamah KO, Leick KM, Bender SM, Greenlee JD. Cervical decompression and reconstruction without intraoperative neurophysiological monitoring. J Neurosurg Spine 2012;16:107–113.
13.
HCUP Nationwide Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP). Available at: http://www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed October 12, 2014.
14.
HCUP National Inpatient Sample (NIS) 2012. Healthcare Cost and Utilization Project (HCUP). Available at: http://www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed October 12, 2014.
15.
Houchens R, Ross D, Elixauser A, Jiang J. Nationwide Inpatient Sample Redesign Final Report. Rockville, MD: Agency for Healthcare Research and Quality; 2014.
16.
Houchens R, Elixhauser A. Using the HCUP Nationwide Inpatient Sample to Estimate Trends. Rockville, MD: Agency for Healthcare Research and Quality; 2006.
17.
Classification of Diseases, Functioning, and Disability, International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). Available at: http://www.cdc.gov/nchs/icd/icd9cm.htm. Accessed July 18, 2014.
18.
von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007;370:1453–1457.
19.
Elixhauser A, Steiner C, Palmer L. Clinical Classifications Software (CCS), 2014. Available at: http://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp. Accessed October 12, 2014.
20.
Andersen R, Newman JF. Societal and individual determinants of medical care utilization in the United States. Milbank Mem Fund Q Health Soc 1973;51:95–124.
21.
Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care 1998;36:8–27.
22.
Kalanithi PS, Patil CG, Boakye M. National complication rates and disposition after posterior lumbar fusion for acquired spondylolisthesis. Spine 2009;34:1963–1969.
23.
Hansen JP. Can't miss: conquer any number task by making important statistics simple: part 6: tests of statistical significance (z test statistic, rejecting the null hypothesis, p value), t test, z test for proportions, statistical significance versus meaningful difference. J Healthc Qual 2004;26:43–53.
24.
Consumer Price Index. Available at: http://www.bls.gov/cpi/. Accessed August 17, 2015.
25.
James WS, Rughani AI, Dumont TM. A socioeconomic analysis of intraoperative neurophysiological monitoring during spine surgery: national use, regional variation, and patient outcomes. Neurosurg Focus 2014;37:E10.
26.
Dekutoski MB, Norvell DC, Dettori JR, Fehlings MG, Chapman JR. Surgeon perceptions and reported complications in spine surgery. Spine 2010;35:S9–S21.
27.
Austin PC, Mamdani MM, Stukel TA, Anderson GM, Tu JV. The use of the propensity score for estimating treatment effects: administrative versus clinical data. Stat Med 2005;24:1563–1578.
28.
Cohn LH, Rosborough D, Fernandez J. Reducing costs and length of stay and improving efficiency and quality of care in cardiac surgery. Ann Thorac Surg 1997;64:S58–S60; discussion S80–S82.
29.
Ney JP, van der Goes DN, Watanabe JH. Cost-effectiveness of intraoperative neurophysiological monitoring for spinal surgeries: beginning steps. Clin Neurophysiol 2012;123:1705–1707.
30.
Ioannidis JP. Adverse events in randomized trials: neglected, restricted, distorted, and silenced. Arch Intern Med 2009;169:1737–1739.
31.
Lawson EH, Louie R, Zingmond DS, et al. A comparison of clinical registry versus administrative claims data for reporting of 30-day surgical complications. Ann Surg 2012;256:973–981.
32.
Tohmeh AG, Rodgers WB, Peterson MD. Dynamically evoked, discrete-threshold electromyography in the extreme lateral interbody fusion approach. J Neurosurg Spine 2011;14:31–37.
33.
Nuwer MR, Cohen BH, Shepard KM. Practice patterns for intraoperative neurophysiologic monitoring. Neurology 2013;80:1156–1160.
34.
Eccher MA, Ghogawala Z, Steinmetz MP. The possibility of clinical trials in neurophysiologic intraoperative monitoring: a review. J Clin Neurophysiol 2014;31:106–111.
35.
Ney JP, van der Goes DN. Evidence-based guideline update: intraoperative spinal monitoring with somatosensory and transcranial electrical motor evoked potentials: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Clinical Neurophysiology Society. Neurology 2012;79:292; author replies 292–294.
36.
Nuwer MR, Emerson RG, Galloway G, et al. Evidence-based guideline update: intraoperative spinal monitoring with somatosensory and transcranial electrical motor evoked potentials. Neurology 2012;78:585–589.
Letters to the Editor
28 October 2015
IOM choosing wisely recommendations
Nitin K. Sethi, Assistant Professor of Neurology

I read with interest the article by Ney et al. and the accompanying comment. [1,2] Intraoperative monitoring (IOM) is now considered the standard of care for spinal surgeries in many centers across the continental United States. Whether IOM improves patient outcome (fewer post-operative neurological complications) and translates into cost of care reduction and overall cost effectiveness is difficult to determine. We may never have an answer.

In today's world of managed care medicine, IOM will come under increasing scrutiny to justify its added cost to surgical care. Like any other neurophysiological modality, there will be spinal and cranial surgeries in which IOM use is justified and others where in it is inappropriate. The onus to identify the surgeries where-in IOM use is medically necessary lies on those who practice IOM. I propose that the American Academy of Neurology in conjunction with the American Clinical Neurophysiological Society publish a set of IOM "Choosing Wisely" recommendations.

1. Ney JP, van der Goes DN, Nuwer MR. Does intraoperative neurophysiologic monitoring matter in noncomplex spine surgeries? Neurology Epub 2015 Oct 7.

2. Husain AM. Neurophysiologic intraoperative monitoring in "low risk" spine surgeries. Neurology Epub 2015 Oct 7.

For disclosures, please contact the editorial office at [email protected].

Information & Authors

Information

Published In

Neurology®
Volume 85Number 24December 15, 2015
Pages: 2151-2158
PubMed: 26446062

Publication History

Received: January 23, 2015
Accepted: July 20, 2015
Published online: October 7, 2015
Published in print: December 15, 2015

Permissions

Request permissions for this article.

Disclosure

J. Ney is the former medical director for Surgical Neuromonitoring Associates and Surgical Neuromonitoring, PLLC, companies that perform intraoperative monitoring. This article was not a term of his employment, nor did he receive any compensation for the article. Dr. Ney has been a consultant for AxelaCare, a home IV infusion company, SpecialtyCare, a surgical services company, and Alliance Life Sciences Consulting. D. van der Goes received funding for a postdoctoral fellowship from Pfizer, Inc. that was completed prior to this manuscript's creation. M. Nuwer is a medical director for SleepMed. Go to Neurology.org for full disclosures.

Study Funding

No targeted funding reported.

Authors

Affiliations & Disclosures

John P. Ney, MD, MPH
From the Comparative Effectiveness, Cost and Outcomes Research Center (J.P.N.), University of Washington, Seattle; the Department of Economics (D.N.v.d.G.), University of New Mexico, Albuquerque; and the Department of Neurology (M.R.N.), University of California, Los Angeles.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
Dr. Ney has received an honorarium from the AAN for speaking at the National Meeting.
Editorial Boards:
1.
Editorial Board, Neurology: Clinical Practice
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
Surgical Neuromonitoring Associates, Medical Director,2011- 2015 Surgical Neuromonitoring, PLLC, Medical Director, 2011-2015
Consultancies:
1.
1)Alliance Life Sciences Consulting Group, paid Clinical Consultant for Health Economics projects 2)AxelaCare Home Health Infusion, paid consultant for statistical and clinical advising 3)SpecialtyCare paid consultant for statistical and clinical advising
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NIH T-32 Training Grant (5-T32-NS051171-02) 2009-2011
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
Expert testimony for plaintiff.
David N. van der Goes, PhD
From the Comparative Effectiveness, Cost and Outcomes Research Center (J.P.N.), University of Washington, Seattle; the Department of Economics (D.N.v.d.G.), University of New Mexico, Albuquerque; and the Department of Neurology (M.R.N.), University of California, Los Angeles.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
(1) Invited speaker at the Annual American Academy of Neurology Meetings in San Diego, 2013.
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
(1) Commercial entity - AlbuQuant LLC (owner): In the past 36 months I have reviewed clinical trial results and reproduced those results. No work was related to neurology, neurological conditions, nor treatment for neurological conditions.
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
(1) I am PI on a grant funded by the American Academy of Neurology. The research is an investigation of the economic value of neurologists in the US health care system. (2) I am an investigator on a project funded by Dialysis Clinic, Inc. Reserve Fund Program. I work on simulation modeling for treatment chronic kidney disease.
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
(1) I am PI on a grant funded by the American Academy of Neurology. The research is an investigation of the economic value of neurologists in the US health care system. (2) I am an investigator on a project funded by Dialysis Clinic, Inc. Reserve Fund Program. I work on simulation modeling for treatment of chronic kidney disease.
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Marc R. Nuwer, MD, PhD
From the Comparative Effectiveness, Cost and Outcomes Research Center (J.P.N.), University of Washington, Seattle; the Department of Economics (D.N.v.d.G.), University of New Mexico, Albuquerque; and the Department of Neurology (M.R.N.), University of California, Los Angeles.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
AAN, ACNS and Virginia Commonwealth Univ funds for travel and speaking at CME events.
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
Royalties for a book, Intraoperative Monitoring, 2008 (Cambridge Press)
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
UCLA Neurology Professional Group, intraoperative spinal cord monitoring, 10% effort, for 38 years
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE

Notes

Correspondence to Dr. Ney: [email protected]
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article. The Article Processing Charge was paid by the University of California.

Author Contributions

Dr. Ney: study concept and design, acquisition of data, analysis and interpretation, critical revision of the manuscript for important intellectual content. Dr. Ney had full access to the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Dr. van der Goes: acquisition of data, analysis and interpretation, analysis and interpretation, analysis and interpretation. Dr. Nuwer: study concept and design, analysis and interpretation, critical revision of the manuscript for important intellectual content, study supervision.

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Cost-benefit analysis of intraoperative neuromonitoring for cardiac surgery, Journal of Stroke and Cerebrovascular Diseases, 33, 3, (107576), (2024).https://doi.org/10.1016/j.jstrokecerebrovasdis.2024.107576
    Crossref
  2. Intraoperative monitoring of the central and peripheral nervous systems: a narrative review, British Journal of Anaesthesia, 132, 2, (285-299), (2024).https://doi.org/10.1016/j.bja.2023.11.032
    Crossref
  3. Intraoperative Neuromonitoring in Spine Surgery, Indian Spine Journal, 6, 1, (15-26), (2023).https://doi.org/10.4103/isj.isj_64_22
    Crossref
  4. Intraoperative neuromonitoring in spine surgery: large database analysis of cost-effectiveness, North American Spine Society Journal (NASSJ), 14, (100206), (2023).https://doi.org/10.1016/j.xnsj.2023.100206
    Crossref
  5. Analyzing the value of IONM as a complex intervention: The gap between published evidence and clinical practice, Clinical Neurophysiology, 151, (59-73), (2023).https://doi.org/10.1016/j.clinph.2023.03.364
    Crossref
  6. Does Neurologic Electrophysiologic Monitoring Affect Outcome?, Evidence-Based Practice of Anesthesiology, (417-429), (2023).https://doi.org/10.1016/B978-0-323-77846-6.00047-1
    Crossref
  7. Intradural extramedullary tumor location in the axial view affects the alert timing of intraoperative neurophysiologic monitoring, Journal of Clinical Monitoring and Computing, 37, 3, (775-782), (2023).https://doi.org/10.1007/s10877-022-00971-6
    Crossref
  8. Diagnostic Value of Multimodal Intraoperative Neuromonitoring by Combining Somatosensory-With Motor-Evoked Potential in Posterior Decompression Surgery for Thoracic Spinal Stenosis, Frontiers in Neuroscience, 16, (2022).https://doi.org/10.3389/fnins.2022.879435
    Crossref
  9. Free-run electromyography assisted interlaminar endoscopic lumbar disckectomy at L4L5 and L5S1 under general anesthesia, Interdisciplinary Neurosurgery, 28, (101524), (2022).https://doi.org/10.1016/j.inat.2022.101524
    Crossref
  10. Monitoring scoliosis and other spinal deformity surgeries, Intraoperative Neuromonitoring, (179-204), (2022).https://doi.org/10.1016/B978-0-12-819826-1.00014-4
    Crossref
  11. See more
Loading...

View Options

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text
Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

Media

Figures

Other

Tables

Share

Share

Share article link

Share